•  Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety, Delage JA, Gnesin S, Prior JO, Barbet J, Le Saëc P, Marionneau-Lambot S, Gouard S, Chérel M, Bourgeois M, Schaefer N, Viertl D, Fierle JK, Dunn SM, Faivre-Chauvet A. Cancers (Basel). 2021 Nov 25;13(23):5936.
    https://doi.org/10.3390/cancers13235936

  • Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model, Delage JA, Faivre-Chauvet A, Barbet J, Fierle JK, Schaefer N, Coukos G, Viertl D, Dunn SM, Gnesin S, Prior JO. Pharmaceutics. 2021 Jan 13;13(1):96. doi: 10.3390/pharmaceutics13010096

  • Cell Tracking in Cancer Immunotherapy, Perrin J, Capitao M, Mougin-Degraef M, Guérard F, Faivre-Chauvet A, Rbah-Vidal L, et al, Front Med. 14 févr 2020;7:34. https://doi.org/10.3389/fmed.2020.00034

  • Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases, Pichon B, Rousseau C, Blanc-Lapierre A, Delpon G, Ferrer L, Libois V, et al, Biomedicines. 28 nov 2020;8(12):548. https://doi.org/10.3390/biomedicines8120548

  • Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease, Gouard S, Maurel C, Marionneau-Lambot S, Dansette D, Bailly C, Guérard F, et al, Cancers. 22 sept 2020;12(9):2721. https://doi.org/10.3390/cancers12092721

  • Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project, Bailly C, Carlier T, Berriolo-Riedinger A, Casasnovas O, Gyan E, Meignan M, et al, Haematologica. janv 2020;105(1):e33‑6. https://doi.org/10.3324/haematol.2019.223016

  • Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer, Le Thiec M, Testard A, Ferrer L, Guillerminet C, Morel O, Maucherat B, et al, Cancers. 9 juin 2020;12(6):1512. https://doi.org/10.3390/cancers12061512

  • ImmunoPET in Multiple Myeloma—What? So What? Now What?, Bailly C, Chalopin B, Gouard S, Carlier T, Remaud-Le Saëc P, Marionneau-Lambot S, et al, Cancers. 4 juin 2020;12(6):1467. https://doi.org/10.3390/cancers12061467

  • Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma, Jamet B, Bailly C, Carlier T, Touzeau C, Michaud A-V, Bourgeois M, et al, Cancers. 19 févr 2020;12(2):486. https://doi.org/10.3390/cancers12020486

  • Haute Couture or Ready-To-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node Detection, Michaud A-V, Samain B, Ferrer L, Fleury V, Dore M, Colombie M, et al, Cancers. 10 avr 2020;12(4):944. https://doi.org/10.3390/cancers12040944